Growth during and 2 years after stopping GH treatment in prepubertal children with idiopathic short stature

Journal of Pediatric Endocrinology and Metabolism

Volumn 10, Issue 2, 1997, Pages 191-196

  Laron, Z ^a   Klinger, B ^a   Anin, S ^a   Pertzelan, A ^a,b   Lilos, P ^b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

idiopathic short stature (ISS); nonconventional hGH treatment

Indexed keywords

HUMAN GROWTH HORMONE; INSULIN; SOMATOMEDIN C;

AGE; ARTICLE; BODY HEIGHT; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; PREPUBERTY; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030995024     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1997.10.2.191     Document Type: Article

References (32)

1. Raiti S, Kaplan SL, Van Vliet G, Moore WV, and the National Hormone and Pituitary Program Growth Hormone Committee. Short-term treatment of short stature and subnormal growth rate with human growth hormone. J Pediatr 1987; 110: 357-361.
2. Albertson-Wikland K, Hall K. Growth hormone treatment in short children: relationships between growth and serum insulin like growth factor I and II levels. J. Clin Endocrinol Metab 1987; 65: 671-678.
3. Hindmarch PC, Bridges NA, Brook CGD. (Review) Wider indications for treatment with biosynthetic growth hormone in children. Clin Endocrinol 1991; 34: 417-427.
4. Westphal O. (Review) Non-conventional growth hormone treatment in short children. Acta Endocrinol 1993; 138 (Suppl 2): 10-11.
5. Hopwood NJ, Hintz RL, Gertner JM, Attie KM, Johanson AG, Baptists J, Kuntze J, Blizzard RM, Cara JF, Chernausik SD, Kaplan SL, Lippe BN, Plotnick LP, Saenger P. Growth response of children with non-growth hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr 1993; 123: 215-222.
6. Chatelain P, Job JC, Blanchard J, Ducret JP, Oliver M, Sagnard L, Vanderschuerren-Lodeweyckx M on behalf of the Belgian and French Pediatric Clinics and Sanofi-Choay (France). Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth retarded children. J Clin Endocrinol Metab 1994; 78: 1454-1460.
7. Low LCK, Kwan E, Karlberg J. A partial transient effect of short-term growth hormone (GH) treatment in short non-GH deficient prepubertal children. J Pediatr Endocrinol Metab 1995; 8: 173-179.
8. Cowell CT. Growth hormone therapy in idiopathic short stature in the Kabi International Growth Study. In: Ranke MB, Gunnarsson R, eds. Progress in Growth Hormone Therapy - 5 Years of KIGS. Mannheim: J & J Verlag, 1994; 216-229.
9. Chatelain P, Nicolino M. Intrauterine growth retardation and Silver-Russell syndrome: demography, auxology and response to growth hormone treatment in the Kabi International Growth Study. In: Ranke MB, Gunnarson R, eds. Progress in Growth Hormone Therapy - 5 Years of KIGS. Mannheim: J & J Verlag 1994; 230-239.
10. Zachmann M. Synergistic effects between hGH and sex hormones. Pediatr Adolesc Endocrinol 1987; 16: 72-87.
11. Bourguignon JP. Importance of timing of puberty for final height of hypopituitary patients. In: Frisch H, Laron Z, eds. Induction of Puberty in Hypopituitarism. Ares-Serono Symposia - Review 16, 1988; 67-81.
12. Darendeliler F, Hindmarsh PL, Preece MA, Cox L, Brooke CG. Growth hormone increases rate of pubertal maturation. Acta Endocrinol 1990; 122: 414-416.
13. Laron Z, Butenandt O. Evaluation of Growth Hormone Secretion. Pediatr Adolesc Endocrinol 1983; 12: pp. 198.
14. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of Hand and Wrist, 2nd Ed. Stanford, CA: Stanford University Press, 1959.
15. Tanner JM, Whitehouse RH, Takahashi M. Standards from birth to maturity for height, weight, height velocity and weight velocity in British children. Arch Dis Child 1966; 41: 613-635.
16. Silbergeld A, Litwin M, Bruchis S, Varsano I, Laron Z. Insulin-like growth factor I (IGF-I) in healthy children, adolescents and adults as determined by a radioimmunoassay specific for the synthetic 53-70 peptide region. Clin Endocrinol 1986; 25: 67-74.
17. Heding LG. Determination of a total serum insulin in treated diabetic patients. Diabetologia 1972; 35: 483.
18. Dixon WJ. BMDP Statistical Software. California: University of California Press, 1990.
19. Guidelines for the use of growth hormone in children with short stature. A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr 1995; 127: 857-867.
20. Guyda HJ. Growth hormone treatment of non-growth hormone deficient subjects: the International Task Force Report. Clin Pediatr Endocrinol 1996; 5 (Suppl 7): 11-18.
21. Bernasconi S, Volta C, Street ME, Mazzardo G, Ferzetti A, Iughetti L, Ghizzoni L. Growth hormone treatment in short normal children. J Pediatr Endocrinol Metab 1996; 9 (Suppl 3): 339-343.
22. Fernandez-Longas A, Mayayo E, Valle A, Soria J, Labarta JI. Constitutional delay in growth and puberty: A comparison of final height achieved between treated and untreated children. J Pediatr Endocrinol Metab 1996; 9 (Suppl 3): 345-357.
23. Chernausek SD, Breen TJ, Frank GR. Linear growth in response to growth hormone treatment in children with short stature associated with intrauterine growth retardation: The National Cooperative Growth Study Experience. J Pediatr 1996; 128 (Suppl): S22-27.
24. Kaplowitz PB. Effect of growth hormone therapy on final versus predicted height in short twelve to sixteen-year old boys without growth hormone deficiency. J Pediatr 1995; 126: 478-480.
25. Zadik Z, Chalew S, Zung A, Landau H, Leiberman E, Koren R, Voet H, Hochberg Z, Kowarski AA. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency. J Pediatr 1994; 125: 189-195.
26. Loche S, Cambiaso P, Setzu S, Carta D, Marini R, Borrelli P, Cappa M. Final height after growth hormone therapy in non-growth hormone deficient children with short stature. J Pediatr 1994; 125: 196-200.
27. Hochberg Z, Leiberman E, Landau H, Koren R, Zadik Z. Age as a determinant of the impact of growth hormone therapy on predicted adult height. Clin Endocrinol 1994; 41: 331-335.
28. Cowell CT, in collaboration with the Australian Paediatric Endocrine Group. Effect of growth hormone in short, slowly growing children without growth hormone deficiency. Acta Paediatr 1990; 226 (Suppl): 29-30.
29. Laron Z, Frenkel J, Deghenghi R, Anin S, Klinger B, Silbergeld A. Intranasal administration of the GHRP - Hexarelin accelerates growth in short children. Clin Endocrinol 1995; 43: 631-635.
30. Holmes CS, Karlsson JA, Thompson RG. Longitudinal evaluation of behaviour patterns in children with short stature. In: Stables B, Underwood LE, eds. Slow Grows the Child, Hillsdale, NY: Lawrence Erlbaum Assoc. Publ., 1986; 1-12.
31. Richman RA, Gordon M, Tegtmeyer P, Crouthamel C, Post EM. Academic and emotional difficulties associated with constitutional short stature. In: Stables B, Underwood LE, eds. Slow Grows the Child. Hillsdale, NY: Lawrence Erlbaum Assoc. Publ., 1986; 13-26.
32. Brat O, Ziv I, Klinger B, Avraham M, Laron Z. Muscle force and endurance in untreated and human growth hormone or insulin-like growth factor-I treated patients with growth hormone deficiency or Laron syndrome. Horm Res 1997; 47: 45-48.